Rui Shi
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 6
- Reproductive Medicine top 10%
- Endometriosis Research and Treatment 5
-
- Circular RNAs in diseases 4
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- RNA Research and Splicing 3
-
- Ferroptosis and cancer prognosis 8
- Co-authors
- Hongbo WangSitian WeiJun ZhangZhicheng YuHua TengXiaoyan XinDilu FengHuaming Tan
- Partner nations
- ChinaUnited KingdomBelarus
In The Last Decade
Rui Shi
38 papers receiving 676 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 201
- Obstetrics and Gynecology 83
- Reproductive Medicine 87
- Immunology 127
- Molecular Biology 350
Countries citing papers authored by Rui Shi
This map shows the geographic impact of Rui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Shi more than expected).
Fields of papers citing papers by Rui Shi
This network shows the impact of papers produced by Rui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Shi. The network helps show where Rui Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinomabreakdown → | 2024 | 63 |
| 7 | 2024 | 20 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 30 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 18 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 53 | |
| 15 | 2021 | 27 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 3 | |
| 18 | 2021 | 10 | |
| 19 | 2019 | 3 | |
| 20 | 2016 | 96 |
About Rui Shi
Rui Shi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 40 papers that have together received 682 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), Endometriosis Research and Treatment (5 papers), Circular RNAs in diseases (4 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (201 citations), Obstetrics and Gynecology (83 citations) and Reproductive Medicine (87 citations). Rui Shi has collaborated with scholars based in China, United Kingdom and Belarus. Frequent co-authors include Hongbo Wang, Sitian Wei, Jun Zhang, Zhicheng Yu, Hua Teng, Xiaoyan Xin, Dilu Feng, Huaming Tan, Min Li and Shuqi Chi. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.